# LBH589 Oral in Combination With Carboplatin and Paclitaxel in Advanced Solid Tumors

> **NCT01159418** · PHASE1 · UNKNOWN · sponsor: **Southern Europe New Drug Organization** · enrollment: 36 (estimated)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** Panobinostat (LBH589), Carboplatin and Paclitaxel

## Key facts

- **NCT ID:** NCT01159418
- **Lead sponsor:** Southern Europe New Drug Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-06
- **Primary completion:** 2011-12
- **Final completion:** 2012-03
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2011-09-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01159418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01159418, "LBH589 Oral in Combination With Carboplatin and Paclitaxel in Advanced Solid Tumors". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01159418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*